Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1117 | 1018 | 1157 | 1059 | 1380 | 2101 |
Fund Return | 11.69% | 1.82% | 15.68% | 1.93% | 6.65% | 7.71% |
Place in category | 250 | 523 | 137 | 325 | 88 | 25 |
% in Category | 41 | 72 | 22 | 59 | 21 | 8 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Pictet CH Institutional Swiss EquiI | 1.73B | 11.30 | 1.45 | 7.20 | ||
Pictet CH Institutional Swiss EquiP | 1.73B | 11.13 | 1.25 | 6.99 | ||
Pictet CH Institutional Swiss EquiZ | 1.73B | 11.68 | 1.93 | 7.71 | ||
Pictet CH Swiss Mid Small Cap Z dy | 1.41B | 5.51 | -1.91 | 9.57 | ||
Pictet CH Institutional Swiss EquID | 1.73B | 2.58 | 3.78 | 6.87 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0033782431 | 2.34B | 12.76 | 4.60 | 6.61 | ||
Raiffeisen Futura Swiss Stock A | 2.18B | 7.92 | -0.59 | 6.39 | ||
UBS CH Equity Fund Swiss Income CHF | 2.02B | 2.43 | 3.56 | 5.81 | ||
UBS CH Equity Fund Swiss Income CHQ | 2.02B | 2.59 | 4.20 | 6.41 | ||
Pictet CH Institutional Swiss EquiZ | 1.73B | 11.68 | 1.93 | 7.71 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Nestle | CH0038863350 | 13.03 | 82.72 | +1.40% | |
Roche Holding Participation | CH0012032048 | 12.31 | 273.10 | +1.94% | |
Novartis | CH0012005267 | 9.80 | 95.49 | +1.80% | |
ABB | CH0012221716 | 6.57 | 48.41 | +1.06% | |
Richemont | CH0210483332 | 5.88 | 126.55 | +0.96% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Neutral | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review